![](/img/cover-not-exists.png)
412 Pathological validation of adjuvant anti-fibroblast growth factor receptor 3 (FGFR3) treatment for bladder cancer
Neuzillet, Y., Mertens, L., Shariat, S., Bostrom, P., Mirtti, T., Sagalowsky, A., Ashfaq, R., Broeks, A., Horenblas, S., Hurst, C., Tomlinson, D., Knowles, M., Bapat, B., Jewett, M., Zlotta, A., SandeVolume:
13
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(14)60407-3
Date:
April, 2014
File:
PDF, 111 KB
english, 2014